Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial

NCT02754765 is registered in ClinicalTrials.gov with Médecins Sans Frontières, France as lead sponsor.

NCT NCT02754765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02754765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Newly Approved Drugs for Multidrug-resistant TB (endTB): A Clinical Trial
Lead sponsor
Médecins Sans Frontières, France
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2016
Completion date
June 30, 2023
Enrollment
754 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

infection, bacterial, pulmonary tuberculoses, tuberculosis, multidrug-resistant